James E. Flynn

Director

Director at Larimar Therapeutics, Inc., filing insider transactions between 2025-06-27 and 2026-02-27. Also reports transactions at 1 other company.

Total Purchases

$25.0M

4 transactions

Total Sales

$13.7M

2 transactions

Companies Traded

6 total filings

Active Since

2025-06-27

Last: 2026-02-27

Companies

Larimar Therapeutics, Inc.

ARS Pharmaceuticals, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-02-27	LRMR	Purchase	1.08M	$5.00	$5.4M	10.62M	SEC ↗
2026-02-27	LRMR	Purchase	1.08M	$5.00	$5.4M	10.62M	SEC ↗
2026-02-27	LRMR	Purchase	2.00M	$5.00	$10.0M